{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:44:37Z","timestamp":1760784277837},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The aim of this review is to highlight recent findings in prevention, diagnosis, and treatment of pediatric osteoporosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Several genes are involved in bone mass acquisition, and various monogenic bone disorders characterized by reduced bone mineral density and increased bone fragility have been recently described. Moreover, many chronic diseases and\/or their treatment have been associated with impaired bone mass acquisition. Pediatric osteoporosis should be adequately suspected and properly diagnosed in children at risk of fractures. Particularly, detection of vertebral fracture allows the diagnosis regardless of densitometric evaluation. Dual X-ray absorptiometry remains the most widely used densitometric technique in childhood, but interpretation of results should be made with caution because of different confounding factors. Bisphosphonates represent one of the main medical treatments of pediatric osteoporosis, and many different protocols have been proposed. Bisphosphonates administration should be characterized by a first phase, followed by a period of maintenance. Optimal route of administration, duration of therapy, and long-term safety of bisphosphonates treatment require further investigation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Careful monitoring of children at risk of fractures is essential to pose early diagnosis of osteoporosis. In children with persistent risk factors and reduced probability of spontaneous recovery, medical treatment with bisphosphonates should be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000423","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T18:40:53Z","timestamp":1496428853000},"page":"535-546","source":"Crossref","is-referenced-by-count":23,"title":["Osteoporosis in childhood"],"prefix":"10.1097","volume":"29","author":[{"given":"Francesco","family":"Vierucci","sequence":"first","affiliation":[{"name":"Pediatric Unit, St. Luca Hospital, Lucca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Saggese","sequence":"additional","affiliation":[{"name":"Pediatric Unit, University Hospital of Pisa, Pisa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[{"name":"Unit of Pediatric Rheumatology, Meyer Children's Hospital, University of Florence, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","first-page":"555","article-title":"Metabolic bone disease and osteoporosis in children: Pediatric rheumatology","author":"Maggio","year":"2016"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpeds.2016.09.056","article-title":"The determinants of peak bone mass","volume":"180","author":"Gordon","year":"2017","journal-title":"J Pediatr"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jpeds.2013.12.040","article-title":"Longitudinal tracking of dual-energy X-ray absorptiometry bone measures over 6 years in children and adolescents: persistence of low bone mass to maturity","volume":"164","author":"Wren","year":"2014","journal-title":"J Pediatr"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s001980070020","article-title":"Peak bone mass","volume":"11","author":"Heaney","year":"2000","journal-title":"Osteoporos Int"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00198-015-3288-6","article-title":"Life-course approach to nutrition","volume":"26","author":"Mitchell","year":"2015","journal-title":"Osteoporos Int"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jbmr.2319","article-title":"The longitudinal effects of physical activity and dietary calcium on bone mass accrual across stages of pubertal development","volume":"30","author":"Lappe","year":"2015","journal-title":"J Bone Miner Res"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s12889-015-2077-7","article-title":"The influence of dairy consumption, sedentary behaviour and physical activity on bone mass in Flemish children: a cross-sectional study","volume":"15","author":"Sioen","year":"2015","journal-title":"BMC Public Health"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/nutrit\/nuu065","article-title":"Combined effects of interaction between physical activity and nutrition on bone health in children and adolescents: a systematic review","volume":"73","author":"Juli\u00e1n-Alm\u00e1rcegui","year":"2015","journal-title":"Nutr Rev"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00223-016-0183-x","article-title":"Associations between body composition and bone health in children and adolescents: a systematic review","volume":"99","author":"Sioen","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2015.03.016","article-title":"Childhood obesity, bone development, and cardiometabolic risk factors","volume":"410","author":"Pollock","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/ije\/dyw079","article-title":"Using mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children","volume":"45","author":"Kemp","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00198-015-3468-4","article-title":"A systematic review and meta-analysis of the association between eating disorders and bone density","volume":"27","author":"Robinson","year":"2016","journal-title":"Osteoporos Int"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2014-2173","article-title":"Committee on Nutrition. Optimizing bone health in children and adolescents","volume":"134","author":"Golden","year":"2014","journal-title":"Pediatrics"},{"key":"R14-20230829","doi-asserted-by":"crossref","DOI":"10.3390\/nu8060319","article-title":"Crucial role of vitamin D in the musculoskeletal system","volume":"8","author":"Wintermeyer","year":"2016","journal-title":"Nutrients"},{"key":"R15-20230829","article-title":"Vitamin D: musculoskeletal health","author":"Bhattoa","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2015-1483","article-title":"Duodenal expression of 25 hydroxyvitamin D3-1\u03b1-hydroxylase is higher in adolescents than in children and adults","volume":"100","author":"Gawlik","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00198-016-3552-4","article-title":"Prevalence of vitamin D insufficiency among adolescents and its correlation with bone parameters using high-resolution peripheral quantitative computed tomography","volume":"27","author":"Cheung","year":"2016","journal-title":"Osteoporos Int"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00431-015-2524-6","article-title":"Vitamin D in childhood and adolescence: an expert position statement","volume":"174","author":"Saggese","year":"2015","journal-title":"Eur J Pediatr"},{"key":"R19-20230829","article-title":"Vitamin D supplementation guidelines","author":"Pludowski","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/EJE-14-0865","article-title":"Endocrinology and adolescence: osteoporosis in children: diagnosis and management","volume":"173","author":"Saraff","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","article-title":"The management of osteoporosis in children","volume":"27","author":"Ward","year":"2016","journal-title":"Osteoporos Int"},{"key":"R23-20230829","first-page":"693","article-title":"The impact of rheumatic diseases and their treatment on bone strength development in childhood","author":"Cimaz","year":"2015","journal-title":"Textbook of pediatric rheumatology"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40265-017-0715-3","article-title":"Pediatric osteoporosis: diagnosis and treatment considerations","volume":"77","author":"Marrani","year":"2017","journal-title":"Drugs"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000381037","article-title":"Primary osteoporosis","volume":"28","author":"Arundel","year":"2015","journal-title":"Endocr Dev"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000381046","article-title":"Genetics of osteoporosis in children","volume":"28","author":"Van Dijk","year":"2015","journal-title":"Endocr Dev"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrrheum.2015.48","article-title":"A look behind the scenes: the risk and pathogenesis of primary osteoporosis","volume":"11","author":"Hendrickx","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2015.12.021","article-title":"Genetic control of bone mass","volume":"432","author":"Boudin","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajmg.a.33909","article-title":"Nosology and classification of genetic skeletal disorders: 2010 revision","volume":"155A","author":"Warman","year":"2011","journal-title":"Am J Med Genet A"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164A","author":"Van Dijk","year":"2014","journal-title":"Am J Med Genet A"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","article-title":"Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment","volume":"27","author":"Trejo","year":"2016","journal-title":"Osteoporos Int"},{"key":"R32-20230829","first-page":"291","article-title":"Bone health in adolescence","volume":"26","author":"Carey","year":"2015","journal-title":"Adolesc Med State Art Rev"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000381045","article-title":"Osteoporosis in children with chronic disease","volume":"28","author":"H\u00f6gler","year":"2015","journal-title":"Endocr Dev"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2016.01.009","article-title":"Update on bone health in pediatric chronic disease","volume":"45","author":"Williams","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semarthrit.2016.02.003","article-title":"The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: a review of current literature","volume":"46","author":"Huber","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0042-110571","article-title":"Glucocorticoid signaling and bone biology","volume":"48","author":"Komori","year":"2016","journal-title":"Horm Metab Res"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11914-014-0228-x","article-title":"Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment","volume":"12","author":"Von Scheven","year":"2014","journal-title":"Curr Osteoporos Rep"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.anai.2016.07.043","article-title":"Inhaled corticosteroids: effects on growth and bone health","volume":"117","author":"Skoner","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11914-016-0308-1","article-title":"The skeletal effects of inhaled glucocorticoids","volume":"14","author":"Sutter","year":"2016","journal-title":"Curr Osteoporos Rep"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.22968","article-title":"Inhaled corticosteroids and bone mineral density at school age: a follow-up study after early childhood wheezing","volume":"50","author":"Sidoroff","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"International Society for Clinical Densitometry. 2013 Pediatric Position Development Conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J Clin Densitom"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-015-3287-7","article-title":"Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis","volume":"27","author":"Moon","year":"2016","journal-title":"Osteoporos Int"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J Clin Densitom"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jocd.2014.01.006","article-title":"Quantitative computer tomography in children and adolescents: the 2013 ISCD Pediatric Official Positions","volume":"17","author":"Adams","year":"2014","journal-title":"J Clin Densitom"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13052-016-0297-9","article-title":"Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review","volume":"42","author":"Stagi","year":"2016","journal-title":"Ital J Pediatr"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"e20162398","DOI":"10.1542\/peds.2016-2398","article-title":"section on endocrinology. Bone densitometry in children and adolescents","volume":"138","author":"Bachrach","year":"2016","journal-title":"Pediatrics"},{"key":"R48-20230829","article-title":"Use of dual energy X-ray absorptiometry in pediatric patients","author":"Wasserman","year":"2016","journal-title":"Bone"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocd.2009.01.005","article-title":"Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery\/Delphi dual-energy X-ray absorptiometry","volume":"12","author":"Zemel","year":"2009","journal-title":"J Clin Densitom"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.091007","article-title":"The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy","volume":"25","author":"Henderson","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.075","article-title":"Prevalence of vertebral fractures in children with suspected osteoporosis","volume":"179","author":"Kyriakou","year":"2016","journal-title":"J Pediatr"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bone.2015.07.032","article-title":"A critical appraisal of vertebral fracture assessment in paediatrics","volume":"81","author":"Kyriakou","year":"2015","journal-title":"Bone"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/jbmr.2511","article-title":"Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders","volume":"30","author":"LeBlanc","year":"2015","journal-title":"J Bone Miner Res"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1210\/JC.2015-2176","article-title":"Incident vertebral fractures in children with leukemia during the four years following diagnosis","volume":"100","author":"Cummings","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-015-0017-9","article-title":"Vitamin D-update for the pediatric rheumatologists","volume":"13","author":"Vojinovic","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000365889","article-title":"The use of bisphosphonates in pediatrics","volume":"82","author":"Baroncelli","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.etap.2016.01.015","article-title":"Bisphosphonates: pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development","volume":"42","author":"Soares","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000381713","article-title":"Efficacy and safety of bisphosphonate therapy in children with osteogenesis imperfecta: a systematic review","volume":"84","author":"Rijks","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.injury.2015.04.021","article-title":"Severe osteogenesis imperfecta type-III and its challenging treatment in newborn and preschool children. A systematic review","volume":"46","author":"Sinikumpu","year":"2015","journal-title":"Injury"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1097\/MJT.0000000000000236","article-title":"Efficacy of bisphosphonates on bone mineral density and fracture rate in patients with osteogenesis imperfecta: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Am J Ther"},{"key":"R62-20230829","first-page":"CD005088","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/archdischild-2015-309934","article-title":"Question 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?","volume":"101","author":"Amin","year":"2016","journal-title":"Arch Dis Child"},{"issue":"(11\u201312)","key":"R64-20230829","first-page":"1343","article-title":"Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis","volume":"28","author":"Kim","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/dmcn.13196","article-title":"Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update","volume":"58","author":"Ozel","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1756-185X.12560","article-title":"Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review","volume":"18","author":"Jayasena","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/eat.22451","article-title":"State of the art systematic review of bone disease in anorexia nervosa","volume":"49","author":"Misra","year":"2016","journal-title":"Int J Eat Disord"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1185\/03007995.2011.645562","article-title":"Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis","volume":"28","author":"Iwasaki","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/jbmr.2567","article-title":"Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years","volume":"30","author":"Palomo","year":"2015","journal-title":"J Bone Miner Res"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000369582","article-title":"The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta","volume":"83","author":"Biggin","year":"2015","journal-title":"Horm Res Paediatr"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201709000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:47:51Z","timestamp":1693291671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201709000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000423","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}